✦ LIBER ✦

Liver transplant induction trial of daclizumab to spare calcineurin inhibition

✍ Scribed by T.G Heffron; G.A Smallwood; T Pillen; L Davis; E Martinez; R Romero; A.C Stieber

Book ID: 117232221
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 49 KB
Volume: 34
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(02)02952-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Calcineurin Inhibitor Sparing With Mycop

Calcineurin Inhibitor Sparing With Mycophenolate Mofetil in Liver Transplantion: A Systematic Review of Randomized Controlled Trials

✍ A. D. Goralczyk; N. Bari; W. Abu-Ajaj; T. Lorf; G. Ramadori; T. Friede; A. Obed 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 680 KB

Randomized liver transplant trial evalua

Randomized liver transplant trial evaluating daclizumab induction while sparing calcineurin inhibition: Thomas G Heffron, Emory University School of Medicine, Atlanta, GA; Gregory A Smallwood, Emory University Hospital, Atlanta, GA; Laurel Davis, Michael De Vera, Enrique Martinez, Andrei Steiber, Emory University School of Medicine, Atlanta, GA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

Following-up of a Four-Dose Daclizumab I

Following-up of a Four-Dose Daclizumab Induction Therapy Without Calcineurin Inhibitors in a Liver Transplantation Recipient With Severe Renal Dysfunction: A Case Report

✍ Y. Zhang; T. Wen; L. Yan; Z. Chen; B. Li; Y. Zeng 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 107 KB

143 SAFETY AND EFFICACY OF STEROID- FREE

143 SAFETY AND EFFICACY OF STEROID- FREE IMMUNOSUPPRESSION POST-LIVER TRANSPLANTATION: A RANDOMISED PHASE III TRIAL COMPARING TACROLIMUS MONOTHERAPY AFTER DACLIZUMAB INDUCTION VERSUS TACROLIMUS+MMF DUAL THERAPY

✍ I. Bilbao; G. Otto; T. Becker; D. D'Amico; M. Colledan; A. Bernardos; S. Beckeba 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 65 KB

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin

Conversion From Calcineurin Inhibitor to

Conversion From Calcineurin Inhibitor to Either Mycophenolate Mofetil or Sirolimus Improves Renal Function in Liver Transplant Recipients With Chronic Kidney Disease: Results of a Prospective Randomized Trial

✍ G. Herlenius; M. Felldin; G. Nordén; M. Olausson; L. Bäckman; B. Gustafsson; S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 764 KB